| Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer AC Pippione, S Kovachka, C Vigato, L Bertarini, I Mannella, S Sainas, ... European Journal of Medicinal Chemistry 268, 116193, 2024 | 4 | 2024 |
| The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents P Linciano, C Pozzi, G Tassone, G Landi, S Mangani, M Santucci, ... European Journal of Medicinal Chemistry 264, 115946, 2024 | 3 | 2024 |
| A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol V Brighenti, M Marani, C Caroli, L Bertarini, A Gaggiotti, F Pollastro, ... Analytical and Bioanalytical Chemistry 416 (20), 4555-4569, 2024 | 1 | 2024 |
| In silico prediction of the interaction of legacy and novel per-and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in … GA Tiburtini, L Bertarini, M Bersani, TA Dragani, B Rolando, A Binello, ... Archives of Toxicology, 1-13, 2024 | 1 | 2024 |
| Structure-Based Optimization of 1, 2, 4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria M Bersani, M Failla, F Vascon, E Gianquinto, L Bertarini, M Baroni, ... Pharmaceuticals 16 (12), 1682, 2023 | 1 | 2023 |
| Targeted Metabolomics for the Analysis of p-Cresol in Mouse Brain: Impact of Biological Sex and Strain L Bertarini, F Imbeni, A Vilella, S Alboni, F Pellati ACS Chemical Neuroscience, 2025 | | 2025 |
| Mechanism of non-competitive inhibition of the SARS-CoV-2 3CL protease dimerization: Therapeutic and clinical promise of the lichen secondary metabolite perlatolinic acid L Fagnani, P Bellio, A Di Giulio, L Nazzicone, R Iorio, S Petricca, ... Heliyon 10 (19), 2024 | | 2024 |
| A new generation of AKR1C3 inhibitors on the horizon: the 3-hydroxybenzazole approach to target prostate cancer C Vigato, AC Pippione, S Sainas, I Mannella, L Bertarini, S Kovachka, ... Proceedings of the Merck Young Chemist’s Symposium 2023, XXII Ed., 197-197, 2023 | | 2023 |
| New Carbapenemases Inhibitors: pyrrolidine-3-carboxylic acids and 1, 2, 4-triazole-3-thiones as promising scaffolds active against Class A and Class B β-lactamases L BERTARINI | | 2022 |
| BROAD SPECTRUM METALLO beta-LACTAMASES INHIBITORS: NEW TOOLS AGAINST CLINICALLY-RELEVANT CARBAPENEMASES L Lazzarato, M Failla, E Gianquinto, M Bersani, L Bertarini, A Verri, ... Book of abstracts of XXVII National Meeting on Medicinal Chemistry, 42-42, 2022 | | 2022 |
| Looking for broad-spectrum inhibitors targeting carbapenemases S Francesca, G Eleonora, M Bersani, M Failla, B Laura, V Filippo, ... PROTEINE 2022, 2022 | | 2022 |
| –IN SILICO SCREENING OF NOVEL INHIBITORS OF BETA-LACTAMASES L Bertarini, A Verri, D Tondi book_of_abstract_XX_GdCER_20211, 2021 | | 2021 |
| P08–IN SILICO SCREENING OF NOVEL INHIBITORS OF BETA-LACTAMASES L Bertarini, A Verri, D Tondi Book of abstract, 33, 0 | | |
